Project Grant P20CA217231

Summary The National Cancer Institute (NCI) awarded $807,644 to Sloan-Kettering Institute for Cancer Research on August 13, 2025, under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to develop and pilot DESCANSO, a culturally adapted cognitive behavioral therapy (CBT) intervention for Spanish-speaking Latino cancer patients. The project, which extends through July 31, 2030, will produce a novel symptom management intervention designed to treat the co-occurring symptom cluster...

Federal Grant Award Summary Cleveland Clinic Lerner College of Medicine of Case Western Reserve University received a $404,974 Project Grant from the National Cancer Institute under the Cancer Cause and Prevention Research program (CFDA 93.393) for the period September 1, 2025 through August 31, 2027. The award supports research evaluating the adoption, implementation, and maintenance of thermal ablation (TA) as a cervical precancer treatment in El Salvador. This research addresses a critical...

Federal Project Grant Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of Cincinnati $186,613 on April 10, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct a five-year neuroimaging research study examining the relationship between activated microglia and cognitive deficits in adults with sickle cell disease (SCD). The primary deliverables include: (1) measurement and mapping of regional and whole-brain activated microglia...

This Project Grant award for $299,712 from the National Science Foundation's (NSF) Integrative Activities program (CFDA 47.083) supports the development of electrochemical aptamer-based (E-AB) sensors for the rapid and accurate detection of multiple cardiovascular disease (CVD) biomarkers. The University of South Carolina, with mentorship from collaborators at the University of Cincinnati, will design and characterize these multiplexed E-AB sensors to enable early diagnosis of CVDs, which are...

This Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $777,954 to the Icahn School of Medicine at Mount Sinai to conduct research on improving preconception cardiovascular health among adolescents. The key products and services to be delivered through this grant include: Constructing a school-based adolescent preconception cohort through data linkages to study the influence of school environments on cardiovascular risk...

Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded The Ohio State University a $765,931 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) on August 22, 2025, to support a multi-center hybrid effectiveness-implementation trial titled "Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults with Sickle Cell Disease (PF-GUIDE)." The grant funds the development and evaluation of patient-centered, evidence-based...

Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded $1,894,767 to the University of California, San Francisco under the Cardiovascular Diseases Research program (CFDA 93.837) for the Community-Based Implementation of Hypertension Screening and Telehealth Systems in Kenya (COMPASS) project. The award, effective September 20, 2025, through June 30, 2030, supports a research initiative examining implementation strategies for integrating community health...

Federal Grant Award Summary The University of North Carolina at Chapel Hill received a $171,488 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded on September 30, 2025, with completion targeted for August 31, 2026. This grant funds a nationwide examination of access to comprehensive care in sickle cell disease (SCD), addressing critical gaps in population-level data regarding the estimated 100,000...

Federal Cooperative Agreement Summary Cincinnati Children's Hospital Medical Center has been awarded $6.45 million through a Cooperative Agreement from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective May 15, 2026 through April 30, 2032. The award funds the establishment and operation of the Bench to Bassinet (B2B) Congenital Heart Disease (CHD) Advancing New Understanding in Genomics (CHANGE) Cohort as a Data...

Federal Project Grant Award Summary Connecticut Children's Medical Center received a $156,340 project grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded June 15, 2025, with completion targeted by May 31, 2030. This Mentored Patient-Oriented Research Career Development (K23) award supports Dr. Siddika Mulchan's five-year research program investigating provider-focused interventions to improve health outcomes...